Heianza Y, Hara S, Arase Y, et al: HbA1c 5.7- 6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet. Jul 9 2011; 378 (9786) : 147-155.
Heianza Y, Arase Y, Kodama S, et al: Trajectory of body mass index before the development of type 2 diabetes in Japanese men: Toranomon Hospital Health Management Center Study 15. J Diabetes Investig. May 2015; 6 (3) : 289-294.
Heianza Y, Suzuki A, Fujihara K, et al: Impact on short-term glycaemic control of initiating diabetes care versus leaving diabetes untreated among individuals with newly screening-detected diabetes in Japan. J Epidemiol Community Health. Dec 2014; 68 (12) : 1189-1195.
Fujihara K, Igarashi R, Yamamoto M, et al: Impact of glucose tolerance status on the development of coronary artery disease among working-age men. Diabetes Metab. Jun 2017; 43 (3) : 261-264.
Fujihara K, Hanyu O, Heianza Y, et al: Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists. J Diabetes Investig. Mar 2016; 7 (2) : 260-269.